| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 4.27e-05 | 2 | 131 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 1.28e-04 | 3 | 131 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | ADP binding | 2.75e-04 | 48 | 131 | 4 | GO:0043531 | |
| GeneOntologyCellularComponent | annulate lamellae | 8.14e-05 | 14 | 130 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | small-subunit processome | 1.12e-04 | 76 | 130 | 5 | GO:0032040 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.79e-04 | 18 | 130 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | somatodendritic compartment | AGO2 ANK3 GLRX3 SMURF1 SRCIN1 GRM2 PEX5L GHR CRYAB WASHC5 PTPRZ1 SYT4 OSBP2 PLCB4 TRPM1 DMD ARHGEF2 FKBP4 HNRNPR | 2.12e-04 | 1228 | 130 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.48e-04 | 20 | 130 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | costamere | 3.32e-04 | 22 | 130 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | astrocyte projection | 4.89e-04 | 25 | 130 | 3 | GO:0097449 | |
| GeneOntologyCellularComponent | preribosome | 7.35e-04 | 114 | 130 | 5 | GO:0030684 | |
| GeneOntologyCellularComponent | box C/D methylation guide snoRNP complex | 7.90e-04 | 7 | 130 | 2 | GO:0031428 | |
| GeneOntologyCellularComponent | box C/D RNP complex | 7.90e-04 | 7 | 130 | 2 | GO:0170049 | |
| GeneOntologyCellularComponent | dendrite | AGO2 ANK3 GLRX3 SRCIN1 GRM2 PEX5L CRYAB PTPRZ1 SYT4 OSBP2 PLCB4 TRPM1 ARHGEF2 HNRNPR | 9.19e-04 | 858 | 130 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | AGO2 ANK3 GLRX3 SRCIN1 GRM2 PEX5L CRYAB PTPRZ1 SYT4 OSBP2 PLCB4 TRPM1 ARHGEF2 HNRNPR | 9.40e-04 | 860 | 130 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.05e-03 | 8 | 130 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.55e-03 | 349 | 130 | 8 | GO:0031965 | |
| GeneOntologyCellularComponent | perineuronal net | 1.67e-03 | 10 | 130 | 2 | GO:0072534 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.67e-03 | 10 | 130 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 2.03e-03 | 11 | 130 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | collagen trimer | 2.23e-03 | 88 | 130 | 4 | GO:0005581 | |
| Domain | PGLYCERATE_KINASE | 4.52e-05 | 2 | 126 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 4.52e-05 | 2 | 126 | 2 | IPR015824 | |
| Domain | - | 4.52e-05 | 2 | 126 | 2 | 3.40.50.1270 | |
| Domain | - | 4.52e-05 | 2 | 126 | 2 | 3.40.50.1260 | |
| Domain | PGK | 4.52e-05 | 2 | 126 | 2 | PF00162 | |
| Domain | SSU_processome_Utp14 | 4.52e-05 | 2 | 126 | 2 | IPR006709 | |
| Domain | Phosphoglycerate_kinase_CS | 4.52e-05 | 2 | 126 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 4.52e-05 | 2 | 126 | 2 | IPR015901 | |
| Domain | Utp14 | 4.52e-05 | 2 | 126 | 2 | PF04615 | |
| Domain | - | RGPD4 ITGB1BP1 PLEKHH3 APPL2 RGPD3 MTMR3 OSBP2 FGD5 PLCB4 ARHGEF2 VAV1 | 6.94e-05 | 391 | 126 | 11 | 2.30.29.30 |
| Domain | TPR-contain_dom | 7.12e-05 | 150 | 126 | 7 | IPR013026 | |
| Domain | TPR_REGION | 1.29e-04 | 165 | 126 | 7 | PS50293 | |
| Domain | TPR | 1.29e-04 | 165 | 126 | 7 | PS50005 | |
| Domain | Phosphoglycerate_kinase | 1.35e-04 | 3 | 126 | 2 | IPR001576 | |
| Domain | PH_dom-like | RGPD4 ITGB1BP1 PLEKHH3 APPL2 RGPD3 MTMR3 OSBP2 FGD5 PLCB4 ARHGEF2 VAV1 | 1.48e-04 | 426 | 126 | 11 | IPR011993 |
| Domain | TPR | 2.42e-04 | 129 | 126 | 6 | SM00028 | |
| Domain | TPR_repeat | 2.85e-04 | 133 | 126 | 6 | IPR019734 | |
| Domain | Rab_bind | 9.27e-04 | 7 | 126 | 2 | PF16704 | |
| Domain | GPCR_kinase | 9.27e-04 | 7 | 126 | 2 | IPR000239 | |
| Domain | GCC2_Rab_bind | 9.27e-04 | 7 | 126 | 2 | IPR032023 | |
| Domain | TPR-like_helical_dom | 1.03e-03 | 233 | 126 | 7 | IPR011990 | |
| Domain | C1Q | 1.29e-03 | 32 | 126 | 3 | SM00110 | |
| Domain | C1q | 1.29e-03 | 32 | 126 | 3 | PF00386 | |
| Domain | C1q_dom | 1.54e-03 | 34 | 126 | 3 | IPR001073 | |
| Domain | C1Q | 1.54e-03 | 34 | 126 | 3 | PS50871 | |
| Domain | - | 1.96e-03 | 10 | 126 | 2 | 1.10.220.60 | |
| Domain | KH_1 | 2.13e-03 | 38 | 126 | 3 | PF00013 | |
| Domain | - | 2.29e-03 | 39 | 126 | 3 | 3.30.1370.10 | |
| Domain | Grip | 2.39e-03 | 11 | 126 | 2 | SM00755 | |
| Domain | GRIP | 2.39e-03 | 11 | 126 | 2 | PF01465 | |
| Domain | KH | 2.47e-03 | 40 | 126 | 3 | SM00322 | |
| Domain | KH_dom | 2.47e-03 | 40 | 126 | 3 | IPR004087 | |
| Domain | Collagen | 2.62e-03 | 85 | 126 | 4 | IPR008160 | |
| Domain | Collagen | 2.62e-03 | 85 | 126 | 4 | PF01391 | |
| Domain | PH | 2.81e-03 | 278 | 126 | 7 | SM00233 | |
| Domain | - | 2.82e-03 | 207 | 126 | 6 | 1.25.40.10 | |
| Domain | KH_TYPE_1 | 2.84e-03 | 42 | 126 | 3 | PS50084 | |
| Domain | Ran_BP1 | 2.85e-03 | 12 | 126 | 2 | PF00638 | |
| Domain | RANBD1 | 2.85e-03 | 12 | 126 | 2 | PS50196 | |
| Domain | GRIP_dom | 2.85e-03 | 12 | 126 | 2 | IPR000237 | |
| Domain | GRIP | 2.85e-03 | 12 | 126 | 2 | PS50913 | |
| Domain | PH_domain | 2.93e-03 | 280 | 126 | 7 | IPR001849 | |
| Domain | TPR_1 | 3.23e-03 | 90 | 126 | 4 | IPR001440 | |
| Domain | TPR_1 | 3.23e-03 | 90 | 126 | 4 | PF00515 | |
| Domain | KH_dom_type_1 | 3.24e-03 | 44 | 126 | 3 | IPR004088 | |
| Domain | RanBD | 3.35e-03 | 13 | 126 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 3.35e-03 | 13 | 126 | 2 | IPR000156 | |
| Domain | ATP_GRASP | 3.90e-03 | 14 | 126 | 2 | PS50975 | |
| Domain | ATP-grasp | 3.90e-03 | 14 | 126 | 2 | IPR011761 | |
| Domain | - | 4.48e-03 | 15 | 126 | 2 | 3.30.1490.20 | |
| Domain | - | 4.66e-03 | 50 | 126 | 3 | 2.60.120.40 | |
| Domain | TPR_2 | 4.66e-03 | 50 | 126 | 3 | PF07719 | |
| Domain | TPR_2 | 4.66e-03 | 50 | 126 | 3 | IPR013105 | |
| Domain | ATP_grasp_subdomain_1 | 6.44e-03 | 18 | 126 | 2 | IPR013815 | |
| Domain | - | 6.44e-03 | 18 | 126 | 2 | 3.30.470.20 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | AARS1 AGO2 ACACA SELENBP1 ANK3 COPB1 MYCBP2 DYNC2H1 GLRX3 IARS1 PSMC3 EIF5A2 APRT PGK1 RYR1 NOP58 AHNAK CNDP2 WDR1 FKBP4 | 3.30e-11 | 807 | 132 | 20 | 30575818 |
| Pubmed | ATXN2L AARS1 ACACA COPB1 MYCBP2 FBL UTP14A PSMC3 ZNF318 PGK1 PNPT1 NOP58 AHNAK MKI67 SCAF11 FKBP4 ZMYM3 NUP153 | 6.28e-11 | 653 | 132 | 18 | 22586326 | |
| Pubmed | ATXN2L AGO2 SELENBP1 ANK3 COPB1 IARS1 SMURF1 PSMC3 EIF5A2 SRCIN1 GRM2 SUCLA2 PGK1 CRYAB GPD1L APPL2 WASHC5 PTPRZ1 MICAL2 VCAN DMD WDR1 ARHGEF2 HNRNPR | 8.75e-10 | 1431 | 132 | 24 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AARS1 AGO2 ACACA COPB1 MYCBP2 FBL IARS1 UTP14A PSMC3 PNO1 PGK1 GSPT1 NOP58 PLAA WASHC5 MICAL2 AHNAK MKI67 DDX43 WDR1 ARHGEF2 ZMYM3 HNRNPR | 1.60e-09 | 1353 | 132 | 23 | 29467282 |
| Pubmed | ATXN2L AGO2 ACACA SELENBP1 COPB1 FBL IARS1 UTP14A PSMC3 PNO1 APRT PGK1 GSPT1 PNPT1 NOP58 MICAL2 MKI67 CNDP2 WDR1 ARHGEF2 FKBP4 HNRNPR | 1.93e-09 | 1247 | 132 | 22 | 27684187 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ATXN2L AARS1 FOXK2 ACACA ANK3 COPB1 MYCBP2 GLRX3 IARS1 PSMC3 APRT PGK1 GSPT1 NOP58 AHNAK IQCB1 EIF3G WDR1 FKBP4 NUP153 HNRNPR | 2.53e-09 | 1149 | 132 | 21 | 35446349 |
| Pubmed | AGO2 ANK3 MYCBP2 PSMC3 CLCC1 PPM1A FANCD2 POSTN WASHC5 PTPRZ1 AHNAK KCTD3 MKI67 MTMR3 DMD ARHGEF2 CPSF2 SLC29A1 FKBP4 NUP153 | 3.10e-09 | 1049 | 132 | 20 | 27880917 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAAP1 ACACA COPB1 FBL IARS1 UTP14A PSMC3 PNO1 APRT SUCLA2 GSPT1 NOP58 WASHC5 AHNAK MKI67 CNDP2 DDX43 EIF3G ARHGEF2 CPSF2 NUP153 HNRNPR | 5.28e-09 | 1318 | 132 | 22 | 30463901 |
| Pubmed | ATXN2L AARS1 AGO2 COPB1 FBL IARS1 PSMC3 PGK1 AHNAK MKI67 EIF3G FKBP4 NUP153 HNRNPR | 6.73e-09 | 494 | 132 | 14 | 26831064 | |
| Pubmed | ATXN2L AARS1 FOXK2 MYCBP2 GLRX3 C9orf78 IARS1 PSMC3 ZNF318 JMJD1C PGK1 GSPT1 KMT2C NOP58 MKI67 ARHGEF2 FKBP4 ZMYM3 NUP153 HNRNPR | 7.21e-09 | 1103 | 132 | 20 | 34189442 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | ACACA MYCBP2 FBL UTP14A PNO1 EIF5A2 ZNF318 APRT JMJD1C PGK1 NOP58 ARHGEF2 FKBP4 NUP153 HNRNPR | 1.70e-08 | 624 | 132 | 15 | 33729478 |
| Pubmed | AGO2 ACACA MYCBP2 UBL4A ZNF318 JMJD1C GSPT1 WASHC5 AHNAK CLSPN | 3.28e-08 | 242 | 132 | 10 | 34011540 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 ATXN2L ACACA COPB1 FBL IARS1 PSMC3 SUCLA2 JMJD1C PGK1 PGK2 GSPT1 NOP58 PLAA RGPD3 | 3.91e-08 | 665 | 132 | 15 | 30457570 |
| Pubmed | COPB1 C9orf78 UBL4A PGK1 CLCC1 GSPT1 NOP58 AHNAK FGD5 EIF3G DMD WDR1 ARHGEF2 CPSF2 FKBP4 VAV1 NUP153 | 7.71e-08 | 916 | 132 | 17 | 32203420 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 STAG1 COPB1 FBL C9orf78 PGK1 RMI1 PTTG3P NOP58 PLAA WASHC5 AHNAK RGPD3 MKI67 EIF3G ZMYM3 NUP153 HNRNPR NAA16 | 8.21e-08 | 1155 | 132 | 19 | 20360068 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ATXN2L AARS1 COPB1 FBL IARS1 UTP14A PSMC3 PGK1 PPM1A NOP58 MKI67 EIF3G WDR1 CPSF2 HNRNPR | 9.82e-08 | 714 | 132 | 15 | 28302793 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.38e-07 | 13 | 132 | 4 | 31427429 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF133 FOXK2 AGO2 GALNT2 ACACA ANK3 MYCBP2 SLC22A23 SMURF1 SRCIN1 SUCLA2 JMJD1C CLCC1 HPS3 KMT2C MICAL2 CNDP2 SCAF11 PLCB4 CFAP69 PDZD2 | 2.10e-07 | 1489 | 132 | 21 | 28611215 |
| Pubmed | CTRP8 and CTRP9B are novel proteins that hetero-oligomerize with C1q/TNF family members. | 2.13e-07 | 4 | 132 | 3 | 19666007 | |
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 14697343 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L CAAP1 ACACA MYCBP2 C9orf78 ZNF318 FANCD2 PASK MKI67 SCAF11 EIF3G ARHGEF2 CPSF2 ZMYM3 NUP153 | 2.75e-07 | 774 | 132 | 15 | 15302935 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | ZNF133 SELENBP1 GLRX3 C9orf78 ITGB1BP1 UTP14A PNO1 MAPKAPK5 JMJD1C KBTBD7 RMI1 KMT2C MKI67 OSBP2 EIF3G WDR1 VAV1 HNRNPR | 2.75e-07 | 1124 | 132 | 18 | 21900206 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SELENBP1 DYNC2H1 FBL APAF1 SMURF1 SCEL APRT SUCLA2 RYR1 FABP1 CRYAB APPL2 AHNAK CNDP2 WDR1 FKBP4 NAA16 | 3.32e-07 | 1016 | 132 | 17 | 19056867 |
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 3.58e-07 | 313 | 132 | 10 | 16196087 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GALNT2 COPB1 MYCBP2 FBL IARS1 UTP14A ZNF318 APRT PGK1 NOP58 AHNAK MKI67 ARHGEF2 CPSF2 FKBP4 NUP153 HNRNPR | 3.70e-07 | 1024 | 132 | 17 | 24711643 |
| Pubmed | RGPD4 STAG1 GRK5 UTP14A CC2D1B ZNF318 ZFC3H1 PGK1 PGK2 GSPT1 RUNDC3A FAM186A AHNAK RGPD3 DMD ARHGEF2 CFAP69 PCDHGA8 HNRNPR UTP14C | 5.50e-07 | 1442 | 132 | 20 | 35575683 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.12e-07 | 332 | 132 | 10 | 32786267 | |
| Pubmed | 6.29e-07 | 333 | 132 | 10 | 36779763 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | AARS1 ACACA COPB1 GLRX3 C9orf78 IARS1 PSMC3 PNO1 CC2D1B GSPT1 FANCD2 PLAA APPL2 WASHC5 AHNAK CNDP2 EIF3G WDR1 FKBP4 HNRNPR | 6.32e-07 | 1455 | 132 | 20 | 22863883 |
| Pubmed | ATXN2L COPB1 FBL COL28A1 PSMC3 PNO1 UBL4A NOP58 PLAA EIF3G ARHGEF2 CPSF2 CLSPN NUP153 HNRNPR UTP14C | 9.23e-07 | 971 | 132 | 16 | 33306668 | |
| Pubmed | 9.77e-07 | 86 | 132 | 6 | 37253089 | ||
| Pubmed | AARS1 ACACA COPB1 GLRX3 IARS1 PSMC3 UBL4A SUCLA2 PNPT1 WDR1 NUP153 HNRNPR | 9.99e-07 | 534 | 132 | 12 | 35032548 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATXN2L AARS1 ACACA COPB1 FBL IARS1 SUCLA2 ITGAM PGK1 CLCC1 GSPT1 CRYAB NOP58 PLAA WASHC5 AHNAK EIF3G WDR1 FKBP4 | 1.06e-06 | 1367 | 132 | 19 | 32687490 |
| Pubmed | ATXN2L COPB1 FBL IARS1 PSMC3 PGK1 AHNAK MKI67 CNDP2 EIF3G DMD WDR1 | 1.08e-06 | 538 | 132 | 12 | 28524877 | |
| Pubmed | ATXN2L COPB1 FBL IARS1 PNO1 APRT PGK1 NOP58 PLAA MKI67 EIF3G WDR1 NUP153 | 1.09e-06 | 641 | 132 | 13 | 36057605 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.73e-06 | 289 | 132 | 9 | 23752268 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | AARS1 ACACA GLRX3 FBL C9orf78 IARS1 UTP14A PSMC3 PNO1 EIF5A2 PGK1 GSPT1 PNPT1 NOP58 AHNAK SCAF11 EIF3G ARHGEF2 HNRNPR | 1.75e-06 | 1415 | 132 | 19 | 28515276 |
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 15448183 | ||
| Pubmed | TSHZ3 FOXK2 AGO2 KBTBD6 COPB1 IARS1 UTP14A PSMC3 ZNF318 JMJD1C KMT2C MKI67 SCAF11 EIF3G WDR1 CPSF2 FKBP4 ZMYM3 HNRNPR | 2.03e-06 | 1429 | 132 | 19 | 35140242 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 2.36e-06 | 25 | 132 | 4 | 19373938 | |
| Pubmed | AARS1 FBL PSMC3 EIF5A2 SUCLA2 PGK1 NOP58 AHNAK MKI67 CNDP2 TRPM1 WDR1 FKBP4 HNRNPR | 2.42e-06 | 803 | 132 | 14 | 36517590 | |
| Pubmed | ATXN2L AARS1 COPB1 MYCBP2 IARS1 PNO1 PNPT1 NOP58 AHNAK EIF3G DMD ARHGEF2 NUP153 HNRNPR | 2.64e-06 | 809 | 132 | 14 | 32129710 | |
| Pubmed | Localization of the mdx mutation within the mouse dystrophin gene. | 2.95e-06 | 8 | 132 | 3 | 2903046 | |
| Pubmed | ATXN2L FOXK2 GLRX3 PSMC3 ZNF318 GSPT1 AHNAK MKI67 EIF3G FKBP4 | 3.18e-06 | 399 | 132 | 10 | 35987950 | |
| Pubmed | ATXN2L AARS1 ACACA COPB1 GLRX3 FBL IARS1 APRT PGK1 NOP58 AHNAK FKBP4 HNRNPR | 3.19e-06 | 707 | 132 | 13 | 19738201 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ATXN2L GALNT2 COPB1 FBL IARS1 ZFC3H1 JMJD1C CLCC1 NOP58 WASHC5 MICAL2 AHNAK MKI67 WDR1 SLC29A1 ZMYM3 HNRNPR | 3.30e-06 | 1203 | 132 | 17 | 29180619 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ATXN2L AARS1 COPB1 IARS1 PSMC3 APRT PGK1 GSPT1 NOP58 PLAA EIF3G FKBP4 | 3.74e-06 | 607 | 132 | 12 | 39147351 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L CAAP1 AGO2 ACACA MYCBP2 IARS1 UTP14A ZFC3H1 GSPT1 NOP58 AHNAK MKI67 HNRNPR | 4.13e-06 | 724 | 132 | 13 | 36232890 |
| Pubmed | Antigens recognized by autologous antibody in patients with renal-cell carcinoma. | 4.30e-06 | 63 | 132 | 5 | 10508479 | |
| Pubmed | ATXN2L CAAP1 FOXK2 AGO2 COPB1 FBL APRT SUCLA2 PGK1 FABP1 PNPT1 NOP58 AHNAK MKI67 SCAF11 TRPM1 ARHGEF2 CPSF2 | 4.60e-06 | 1371 | 132 | 18 | 36244648 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ACACA FBL UTP14A PSMC3 PNO1 EIF5A2 JMJD1C NOP58 AHNAK MKI67 SCAF11 CLSPN FKBP4 NUP153 HNRNPR | 5.64e-06 | 989 | 132 | 15 | 36424410 |
| Pubmed | ANK3 GSPT1 GPD1L SERPINB9 PLAA MICAL2 MKI67 SCAF11 WDR1 FKBP4 NUP153 HNRNPR | 5.81e-06 | 634 | 132 | 12 | 34591612 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ATXN2L FBL IARS1 UTP14A PNO1 ZFC3H1 PGK1 NOP58 AHNAK MKI67 SCAF11 EIF3G WDR1 ARHGEF2 FKBP4 NUP153 HNRNPR | 5.89e-06 | 1257 | 132 | 17 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 AGO2 ACACA COPB1 MYCBP2 FBL IARS1 PSMC3 EIF5A2 UBL4A SUCLA2 PPM1A GSPT1 NOP58 RGPD3 CPSF2 HNRNPR | 5.89e-06 | 1257 | 132 | 17 | 37317656 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | GALNT2 MYCBP2 UBL4A ZNF318 SUCLA2 CLCC1 PPM1A GSPT1 FANCD2 PLAA MTMR3 EIF3G NUP153 | 6.38e-06 | 754 | 132 | 13 | 33060197 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ATXN2L FOXK2 SELENBP1 KBTBD6 MYCBP2 DYNC2H1 IARS1 PSMC3 UBL4A SUCLA2 KCTD3 EIF3G ARHGEF2 SCLT1 NUP153 | 6.83e-06 | 1005 | 132 | 15 | 19615732 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | AARS1 ACACA COPB1 DYNC2H1 FBL IARS1 UTP14A PSMC3 SUCLA2 PGK1 GSPT1 FANCD2 NOP58 MKI67 FGD5 FKBP4 NUP153 HNRNPR | 7.80e-06 | 1425 | 132 | 18 | 30948266 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 8.00e-06 | 349 | 132 | 9 | 25665578 | |
| Pubmed | 8.25e-06 | 124 | 132 | 6 | 23000965 | ||
| Pubmed | ATXN2L AGO2 ACACA ANK3 MYCBP2 FBL ZNF318 JMJD1C KMT2C NOP58 AHNAK | 8.51e-06 | 549 | 132 | 11 | 38280479 | |
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 1572636 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 17069463 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 37883229 | ||
| Pubmed | ATXN2L AARS1 AGO2 GALNT2 COPB1 MYCBP2 IARS1 PSMC3 PGK1 CLCC1 NOP58 SERPINB9 AHNAK MKI67 CPSF2 SLC29A1 | 9.66e-06 | 1168 | 132 | 16 | 19946888 | |
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 1.06e-05 | 36 | 132 | 4 | 25615642 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 1.15e-05 | 12 | 132 | 3 | 2561974 | |
| Pubmed | 1.29e-05 | 134 | 132 | 6 | 24816145 | ||
| Pubmed | ATXN2L TSHZ3 KBTBD6 GLRX3 FBL IARS1 UTP14A PSMC3 PNO1 FANCD2 PASK IQCB1 MTMR3 EIF3G ARHGEF2 CPSF2 HNRNPR | 1.29e-05 | 1335 | 132 | 17 | 29229926 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31743468 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25783894 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28513807 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21836066 | ||
| Pubmed | Testosterone inhibits spermatogonial differentiation in juvenile spermatogonial depletion mice. | 1.43e-05 | 2 | 132 | 2 | 11415997 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8441629 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11751268 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32632164 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24473438 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22972916 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27188183 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10499552 | ||
| Pubmed | Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina. | 1.43e-05 | 2 | 132 | 2 | 35575905 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30426302 | ||
| Pubmed | CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells. | 1.43e-05 | 2 | 132 | 2 | 29749459 | |
| Pubmed | The family of mouse phosphoglycerate kinase genes and pseudogenes. | 1.43e-05 | 2 | 132 | 2 | 2829366 | |
| Pubmed | Characterization of phosphoglycerate kinase from human spermatozoa. | 1.43e-05 | 2 | 132 | 2 | 1278465 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29424023 | ||
| Pubmed | CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. | 1.43e-05 | 2 | 132 | 2 | 31837806 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28978553 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32283037 | ||
| Pubmed | C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. | 1.43e-05 | 2 | 132 | 2 | 27821723 | |
| Pubmed | Cessation of spermatogenesis in juvenile spermatogonial depletion (jsd/jsd) mice. | 1.43e-05 | 2 | 132 | 2 | 9354954 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35008006 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21733828 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21435454 | ||
| Pubmed | Analysis of the cDNA and encoded protein of the human testis-specific PGK-2 gene. | 1.43e-05 | 2 | 132 | 2 | 9023984 | |
| Pubmed | Testosterone suppresses spermatogenesis in juvenile spermatogonial depletion (jsd ) mice. | 1.43e-05 | 2 | 132 | 2 | 11466222 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24030394 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 36766785 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37945738 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22514273 | ||
| Interaction | SUMO2 interactions | AARS1 SELENBP1 IARS1 PSMC3 APRT PGK1 ABCA8 FANCD2 MSX1 NOP58 AHNAK MKI67 SCAF11 CPSF2 ZMYM3 NUP153 HNRNPR | 2.95e-07 | 591 | 131 | 17 | int:SUMO2 |
| Interaction | SIRT7 interactions | ATXN2L AARS1 ACACA COPB1 MYCBP2 FBL UTP14A PSMC3 ZNF318 PGK1 KBTBD7 PNPT1 NOP58 AHNAK MKI67 SCAF11 FKBP4 ZMYM3 NUP153 | 3.47e-07 | 744 | 131 | 19 | int:SIRT7 |
| Interaction | LMNA interactions | GALNT2 STAG1 KBTBD6 FBL C9orf78 SMURF1 GRM2 APRT SUCLA2 ITGAM IFIT2 PGK1 FANCD2 NOP58 SERPINB9 WASHC5 MKI67 CNDP2 DDX43 EIF3G NYAP1 FKBP4 NUP153 HNRNPR | 2.53e-06 | 1286 | 131 | 24 | int:LMNA |
| Interaction | AGR2 interactions | AARS1 AGO2 ACACA SELENBP1 ANK3 COPB1 MYCBP2 DYNC2H1 GLRX3 IARS1 PSMC3 EIF5A2 APRT PGK1 RYR1 NOP58 AHNAK CNDP2 WDR1 FKBP4 | 2.56e-06 | 934 | 131 | 20 | int:AGR2 |
| Interaction | BRCA1 interactions | ATXN2L AARS1 AGO2 ACACA STAG1 COPB1 FBL IARS1 PSMC3 PGK1 FANCD2 RMI1 SERPINB9 PLAA MICAL2 AHNAK MKI67 EIF3G CLSPN FKBP4 ZMYM3 NUP153 HNRNPR | 5.29e-06 | 1249 | 131 | 23 | int:BRCA1 |
| Interaction | CEBPA interactions | ATXN2L AARS1 FOXK2 STAG1 MYCBP2 GLRX3 C9orf78 IARS1 PSMC3 ZNF318 JMJD1C PGK1 GSPT1 KMT2C NOP58 MKI67 ARHGEF2 FKBP4 ZMYM3 NUP153 HNRNPR NAA16 | 1.66e-05 | 1245 | 131 | 22 | int:CEBPA |
| Interaction | EED interactions | AARS1 ACACA SELENBP1 STAG1 COPB1 MYCBP2 GLRX3 FBL IARS1 UTP14A LAMA1 PNO1 APRT PGK1 FANCD2 NOP58 WASHC5 CNDP2 PALM3 EIF3G WDR1 CPSF2 VAV1 HNRNPR | 1.81e-05 | 1445 | 131 | 24 | int:EED |
| Interaction | CKAP2 interactions | 1.85e-05 | 126 | 131 | 7 | int:CKAP2 | |
| Interaction | SLX4 interactions | ACACA FBL ZBTB12 ZNF318 ZFC3H1 APRT KBTBD7 FANCD2 NOP58 RGPD3 MKI67 ARHGEF2 CLSPN NUP153 | 2.18e-05 | 572 | 131 | 14 | int:SLX4 |
| Interaction | KCTD13 interactions | ATXN2L AGO2 ANK3 COPB1 IARS1 SMURF1 PSMC3 EIF5A2 SRCIN1 GRM2 SUCLA2 PGK1 CRYAB GPD1L APPL2 WASHC5 PTPRZ1 MICAL2 VCAN DMD WDR1 ARHGEF2 HNRNPR | 3.09e-05 | 1394 | 131 | 23 | int:KCTD13 |
| Interaction | BAP1 interactions | ATXN2L AARS1 FOXK2 ACACA ANK3 COPB1 MYCBP2 GLRX3 IARS1 PSMC3 APRT PGK1 GSPT1 KMT2C NOP58 AHNAK IQCB1 EIF3G WDR1 FKBP4 NUP153 HNRNPR | 3.78e-05 | 1314 | 131 | 22 | int:BAP1 |
| Interaction | PI4KB interactions | 4.41e-05 | 60 | 131 | 5 | int:PI4KB | |
| Interaction | RBM39 interactions | ATXN2L CAAP1 AARS1 ACACA COPB1 FBL IARS1 UTP14A PSMC3 PNO1 PGK1 PPM1A FANCD2 NOP58 MKI67 EIF3G WDR1 CPSF2 HNRNPR | 4.41e-05 | 1042 | 131 | 19 | int:RBM39 |
| Interaction | LDHB interactions | 5.62e-05 | 327 | 131 | 10 | int:LDHB | |
| Interaction | CIT interactions | ATXN2L AARS1 STAG1 COPB1 DYNC2H1 FBL IARS1 UTP14A PSMC3 PNO1 GRM2 NOP58 AHNAK RGPD3 MKI67 SCAF11 WDR1 ARHGEF2 CPSF2 NUP153 HNRNPR CCDC40 UTP14C | 5.68e-05 | 1450 | 131 | 23 | int:CIT |
| Interaction | RCOR1 interactions | TSHZ3 FOXK2 ACACA MYCBP2 C9orf78 ZNF318 JMJD1C GSPT1 AHNAK MKI67 SCLT1 ZMYM3 | 9.33e-05 | 494 | 131 | 12 | int:RCOR1 |
| Interaction | ARF4 interactions | 9.40e-05 | 281 | 131 | 9 | int:ARF4 | |
| Interaction | CCDC8 interactions | GALNT2 COPB1 MYCBP2 FBL IARS1 APAF1 EIF5A2 ZNF318 FANCD2 NOP58 AHNAK MKI67 ARHGEF2 HNRNPR | 9.58e-05 | 656 | 131 | 14 | int:CCDC8 |
| Interaction | SPTAN1 interactions | ANK3 MYCBP2 GRK5 SMURF1 UBL4A PEX5L PPM1A GSPT1 FANCD2 IQCB1 FGD5 HNRNPR | 9.69e-05 | 496 | 131 | 12 | int:SPTAN1 |
| Interaction | ACE2 interactions | ATXN2L GALNT2 ACACA COPB1 FBL IARS1 PNO1 GRM2 APRT PGK1 NOP58 PLAA APPL2 KCTD3 MKI67 EIF3G WDR1 NUP153 HNRNPR | 9.74e-05 | 1106 | 131 | 19 | int:ACE2 |
| Interaction | NR2C2 interactions | CAAP1 ACACA COPB1 FBL IARS1 UTP14A PSMC3 PNO1 APRT SUCLA2 GSPT1 NOP58 WASHC5 AHNAK MKI67 CNDP2 DDX43 EIF3G ARHGEF2 CPSF2 NUP153 HNRNPR | 9.98e-05 | 1403 | 131 | 22 | int:NR2C2 |
| Interaction | B9D2 interactions | 1.13e-04 | 73 | 131 | 5 | int:B9D2 | |
| Interaction | RPS11 interactions | ATXN2L AGO2 FBL UTP14A SMURF1 PNO1 UBL4A GSPT1 FANCD2 NOP58 DDX43 EIF3G | 1.15e-04 | 505 | 131 | 12 | int:RPS11 |
| Interaction | HNRNPA2B1 interactions | ATXN2L AGO2 ACACA MYCBP2 IARS1 SMURF1 PNO1 UBL4A GRM2 IFIT2 PGK1 FANCD2 IQCB1 MKI67 HNRNPR | 1.16e-04 | 754 | 131 | 15 | int:HNRNPA2B1 |
| Interaction | RPS5 interactions | MYCBP2 FBL SMURF1 PNO1 UBL4A GRM2 PGK1 GSPT1 FANCD2 MKI67 EIF3G | 1.20e-04 | 431 | 131 | 11 | int:RPS5 |
| Interaction | VCP interactions | CAAP1 ACACA MYCBP2 GLRX3 IARS1 SMURF1 PSMC3 PNO1 UBL4A GRM2 PGK1 ABCA8 GSPT1 FANCD2 PLAA IQCB1 MKI67 CNDP2 FGD5 WDR1 ARHGEF2 FKBP4 | 1.38e-04 | 1435 | 131 | 22 | int:VCP |
| Interaction | DDA1 interactions | 1.49e-04 | 368 | 131 | 10 | int:DDA1 | |
| Interaction | PABPC4 interactions | ATXN2L AGO2 FBL UBL4A ZFC3H1 APRT IFIT2 GSPT1 WDR1 FKBP4 HNRNPR | 1.49e-04 | 442 | 131 | 11 | int:PABPC4 |
| Interaction | GAPDH interactions | TSHZ3 AGO2 FBL PCDHA4 GRM2 PGK1 RYR1 FANCD2 GPD1L SERPINB9 IQCB1 CNDP2 FGD5 HNRNPR | 1.53e-04 | 686 | 131 | 14 | int:GAPDH |
| Interaction | HSP90AB1 interactions | AARS1 AGO2 ANK3 MYCBP2 C9orf78 GRK5 PSMC3 UBL4A GRM2 PGK1 FANCD2 KMT2C AHNAK IQCB1 SCAF11 FGD5 FKBP4 | 1.64e-04 | 960 | 131 | 17 | int:HSP90AB1 |
| Interaction | KCNA3 interactions | ATXN2L ANK3 COPB1 GLRX3 IARS1 LAMA1 CC2D1B JMJD1C CLCC1 RYR1 KMT2C AHNAK TRPM1 RP1 EIF3G NUP153 | 1.71e-04 | 871 | 131 | 16 | int:KCNA3 |
| Interaction | HOOK1 interactions | 1.77e-04 | 240 | 131 | 8 | int:HOOK1 | |
| Interaction | ENO1 interactions | AARS1 ACACA ANK3 COPB1 FBL C9orf78 ITGAM PGK1 PGK2 FANCD2 FAM186A AHNAK FGD5 WDR1 | 1.91e-04 | 701 | 131 | 14 | int:ENO1 |
| Interaction | GRM2 interactions | 1.97e-04 | 381 | 131 | 10 | int:GRM2 | |
| Interaction | MMS19 interactions | 2.02e-04 | 311 | 131 | 9 | int:MMS19 | |
| Interaction | MCCC1 interactions | 2.24e-04 | 187 | 131 | 7 | int:MCCC1 | |
| Interaction | SNCA interactions | STAG1 COPB1 IARS1 GRK5 APAF1 PSMC3 GRK1 CRYAB APPL2 AHNAK VCAN EIF3G FKBP4 HNRNPR | 2.37e-04 | 716 | 131 | 14 | int:SNCA |
| Interaction | KRT87P interactions | 2.49e-04 | 4 | 131 | 2 | int:KRT87P | |
| Cytoband | 13q14.11 | 1.97e-04 | 39 | 132 | 3 | 13q14.11 | |
| Cytoband | 13q22 | 4.44e-04 | 11 | 132 | 2 | 13q22 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.47e-05 | 115 | 83 | 6 | 769 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 7.24e-05 | 18 | 83 | 3 | 1372 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.70e-04 | 206 | 83 | 6 | 682 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | AARS1 AGO2 STAG1 GLRX3 GRK5 PSMC3 PNO1 GRM2 SUCLA2 PGK1 FANCD2 PASK RMI1 PTTG3P PLAA KCTD3 MKI67 CPSF2 SLC29A1 VAV1 NUP153 HNRNPR | 4.92e-07 | 1290 | 132 | 22 | M80 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | AGO2 GALNT2 FBL IARS1 UTP14A PNO1 EIF5A2 MAPKAPK5 PGK1 CLCC1 GHR POSTN PNPT1 PTTG3P NOP58 MICAL2 VCAN KCTD3 MKI67 DMD FKBP4 | 7.46e-06 | 1407 | 132 | 21 | M14427 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | UBL4A MAPKAPK5 CLCC1 POSTN ZNF182 MKI67 PALM3 SCAF11 CLSPN UTP14C | 1.25e-05 | 291 | 130 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-08 | 180 | 132 | 8 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-08 | 180 | 132 | 8 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-08 | 182 | 132 | 8 | 812ff2a50a510b18d865e89465dba1754a08ef61 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.47e-07 | 199 | 132 | 8 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.33e-07 | 172 | 132 | 7 | f0b658baa4b41329c95a09387cc55ea046e2333f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 182 | 132 | 7 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-06 | 185 | 132 | 7 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-06 | 185 | 132 | 7 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-06 | 185 | 132 | 7 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-06 | 188 | 132 | 7 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 191 | 132 | 7 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 191 | 132 | 7 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.86e-06 | 194 | 132 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-06 | 194 | 132 | 7 | 23b06707d21306b4483d64cb350b86aef352ce38 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-06 | 195 | 132 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-06 | 197 | 132 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.20e-06 | 199 | 132 | 7 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | CV-Moderate-2|Moderate / Virus stimulation, Condition and Cluster | 2.20e-06 | 199 | 132 | 7 | 70d6f2a328eec4cb2cecb7cd85859fba9e15c9c8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-late_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.55e-06 | 144 | 132 | 6 | ca365380ccf5e60d2e3f6272059ff0531759612d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 164 | 132 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 168 | 132 | 6 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-05 | 170 | 132 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-05 | 172 | 132 | 6 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 176 | 132 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.43e-05 | 176 | 132 | 6 | 9af82b976e6a14a3ef7aa50f1f7af2463e5aa5d2 | |
| ToppCell | Healthy-RBC|World / disease group, cell group and cell class | 1.48e-05 | 177 | 132 | 6 | 2ce41e37fa7139c7bd2b464bd86c5601dc501515 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 178 | 132 | 6 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | Multiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.58e-05 | 179 | 132 | 6 | 15763dc59ee6186416e203ffbb450ae4608eba59 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.63e-05 | 180 | 132 | 6 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 180 | 132 | 6 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 180 | 132 | 6 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 180 | 132 | 6 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-05 | 181 | 132 | 6 | 577bf37a6594fad01251d2c66d8ccda8e949b6cf | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-05 | 181 | 132 | 6 | f5dc7a650afe8837cb424981e50ad2c8b18c7c32 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 182 | 132 | 6 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 182 | 132 | 6 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 182 | 132 | 6 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 183 | 132 | 6 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | COVID-19_Severe-RBC|COVID-19_Severe / disease group, cell group and cell class | 1.84e-05 | 184 | 132 | 6 | bb58244194ffb5558fbe85c5f856888210dcb1e8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 184 | 132 | 6 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-05 | 184 | 132 | 6 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.84e-05 | 184 | 132 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 185 | 132 | 6 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.90e-05 | 185 | 132 | 6 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.90e-05 | 185 | 132 | 6 | 100b5afdf3c6ab07ffc493f7883f5a7b31c59184 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 1.90e-05 | 185 | 132 | 6 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 185 | 132 | 6 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.90e-05 | 185 | 132 | 6 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 185 | 132 | 6 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | COVID-19_Severe-RBC|World / disease group, cell group and cell class | 1.90e-05 | 185 | 132 | 6 | 96b7058b1b282134970aa9e75285760a9f94a8b5 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 1.90e-05 | 185 | 132 | 6 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 186 | 132 | 6 | 34ed60e846fd83fab3e28dc9e278bcc4b092a9f0 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 186 | 132 | 6 | 40acd9b4e9b3c1d1527bd4ba17ae830ff18d6e9d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-05 | 187 | 132 | 6 | c4ba9dfedbcf0357a8627af03f4fe1770e985a03 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-05 | 187 | 132 | 6 | 13023661c26aaf9e42262a4ff91f2fb26e8a3eaf | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.02e-05 | 187 | 132 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-05 | 188 | 132 | 6 | da211e7fb62fff176aa9c39061aef9ab0af6079e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | f81099b5b3f1f85a28445bc663efcf73baccb2be | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.08e-05 | 188 | 132 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-05 | 188 | 132 | 6 | 3c6c0eaadc474ebb218ae349b787c410f66177ab | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | 05b3ade422beeb3db73d350fe192c21bfcfef188 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-05 | 188 | 132 | 6 | 3467149de45b47a5015486ef94bec070e9c3ffc2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-05 | 189 | 132 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-05 | 191 | 132 | 6 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.27e-05 | 191 | 132 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | CV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 2.34e-05 | 192 | 132 | 6 | a249787f7e2f50af49bd7d4752c411a067a5e3d3 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 192 | 132 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 192 | 132 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 192 | 132 | 6 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.41e-05 | 193 | 132 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.41e-05 | 193 | 132 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.41e-05 | 193 | 132 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 193 | 132 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.48e-05 | 194 | 132 | 6 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-05 | 194 | 132 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-05 | 116 | 132 | 5 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.55e-05 | 195 | 132 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 15-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 2.55e-05 | 195 | 132 | 6 | 56356a9aeb67b50a74425be2cd9c50d31416c1b3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 195 | 132 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.55e-05 | 195 | 132 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | CV-Severe-2|CV / Virus stimulation, Condition and Cluster | 2.55e-05 | 195 | 132 | 6 | 1cde7f6e6c9c610bacc79014519447112c27dd9d | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 196 | 132 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.63e-05 | 196 | 132 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.63e-05 | 196 | 132 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-05 | 197 | 132 | 6 | 41bdea47b9b1f6415a866a515d1535ea942fdede | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.70e-05 | 197 | 132 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.70e-05 | 197 | 132 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-05 | 197 | 132 | 6 | 2d3547107c88c7443fc6425742694e13368a71f5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.70e-05 | 197 | 132 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-05 | 197 | 132 | 6 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | CV-Mild-2|CV / Virus stimulation, Condition and Cluster | 2.70e-05 | 197 | 132 | 6 | dc1cfba2ee66c62b53accefbfce3025cd760524a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.70e-05 | 197 | 132 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | CV-Severe-2|Severe / Virus stimulation, Condition and Cluster | 2.78e-05 | 198 | 132 | 6 | 254659bb53dc2511c714295c2df1ab1fddb2f867 | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 745e966fd52f06485061727cdbd9358b9df7d97d | |
| ToppCell | Parenchymal-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 24b1138746dd69d1cda419f7070ef5a402d07563 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 2a00648d3aa5843d9e924e054c5e973025f86e97 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 2.78e-05 | 198 | 132 | 6 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| Drug | monastrol; Up 200; 100uM; PC3; HG-U133A | 2.25e-06 | 198 | 131 | 9 | 668_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; HL60; HG-U133A | 1.03e-05 | 181 | 131 | 8 | 2007_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; HL60; HG-U133A | 1.25e-05 | 186 | 131 | 8 | 1548_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; HL60; HG-U133A | 1.25e-05 | 186 | 131 | 8 | 1555_DN | |
| Drug | chloroethylguanine | 1.52e-05 | 9 | 131 | 3 | CID000161383 | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; HL60; HT_HG-U133A | 1.83e-05 | 196 | 131 | 8 | 2942_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.97e-05 | 198 | 131 | 8 | 4492_UP | |
| Drug | ACVDP | 2.17e-05 | 10 | 131 | 3 | CID000501523 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.37e-06 | 148 | 125 | 7 | C0279702 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.82e-05 | 128 | 125 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.82e-05 | 128 | 125 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.82e-05 | 128 | 125 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.82e-05 | 128 | 125 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.82e-05 | 128 | 125 | 6 | C0007134 | |
| Disease | skin disease (implicated_via_orthology) | 5.33e-05 | 3 | 125 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | blood copper measurement | 6.08e-05 | 50 | 125 | 4 | EFO_0007578 | |
| Disease | ICAM-1 measurement | 1.41e-04 | 24 | 125 | 3 | EFO_0004520 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 1.77e-04 | 5 | 125 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 1.77e-04 | 5 | 125 | 2 | C0917713 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.91e-04 | 67 | 125 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | Colorectal Carcinoma | ACACA SELENBP1 LAMA1 PEX5L ABCA8 HPS3 POSTN KMT2C MKI67 DMD SLC29A1 | 2.04e-04 | 702 | 125 | 11 | C0009402 |
| Disease | muscular atrophy (biomarker_via_orthology) | 2.50e-04 | 29 | 125 | 3 | DOID:767 (biomarker_via_orthology) | |
| Disease | Accommodative esotropia | 2.64e-04 | 6 | 125 | 2 | HP_0020046 | |
| Disease | Muscular Dystrophy, Duchenne | 2.64e-04 | 6 | 125 | 2 | C0013264 | |
| Disease | Anti-measles virus IgG measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0009355 | |
| Disease | neuroticism measurement, cognitive function measurement | ATXN2L AGO2 THSD7A GALNT2 STAG1 SLC22A23 PCDHA4 JMJD1C RUNDC3A | 7.05e-04 | 566 | 125 | 9 | EFO_0007660, EFO_0008354 |
| Disease | oral microbiome measurement | 7.55e-04 | 42 | 125 | 3 | EFO_0801229 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 7.84e-04 | 10 | 125 | 2 | DOID:7693 (is_marker_for) | |
| Disease | cytokine measurement | 7.99e-04 | 461 | 125 | 8 | EFO_0004873 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.14e-03 | 12 | 125 | 2 | C0403553 | |
| Disease | cirrhosis of liver | 1.35e-03 | 13 | 125 | 2 | EFO_0001422 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.35e-03 | 13 | 125 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | factor VIII measurement, coronary artery disease | 1.38e-03 | 113 | 125 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.66e-03 | 55 | 125 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Liver Cirrhosis, Experimental | ERN1 SLC22A23 APAF1 GHR CRYAB LURAP1L SERPINB9 AHNAK MKI67 VAV1 | 1.72e-03 | 774 | 125 | 10 | C0023893 |
| Disease | fibrinogen measurement, factor VII measurement | 1.93e-03 | 58 | 125 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 2.13e-03 | 60 | 125 | 3 | EFO_0021898 | |
| Disease | Night blindness, congenital stationary | 2.32e-03 | 17 | 125 | 2 | C0339535 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 2.34e-03 | 62 | 125 | 3 | EFO_0022263 | |
| Disease | body weight | ATXN2L ZNF133 AARS1 COPB1 C1QTNF9B PSMC3 PGK1 GHR MTMR3 SYT4 DMD CPSF2 PDZD2 | 2.72e-03 | 1261 | 125 | 13 | EFO_0004338 |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.76e-03 | 225 | 125 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | age at onset, smoking initiation | 2.90e-03 | 19 | 125 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | corneal resistance factor | 3.16e-03 | 451 | 125 | 7 | EFO_0010067 | |
| Disease | susceptibility to mononucleosis measurement | 3.17e-03 | 69 | 125 | 3 | EFO_0008403 | |
| Disease | Alzheimer disease, age at onset | 3.48e-03 | 343 | 125 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 3.55e-03 | 21 | 125 | 2 | EFO_0022262 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.58e-03 | 72 | 125 | 3 | EFO_0022336 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.83e-03 | 243 | 125 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | juvenile idiopathic arthritis | 3.86e-03 | 74 | 125 | 3 | EFO_0002609 | |
| Disease | mean platelet volume | FOXK2 GALNT2 TEX2 SLC22A23 GRK5 UTP14A SMURF1 JMJD1C PGK1 PCDHGA8 VAV1 | 4.12e-03 | 1020 | 125 | 11 | EFO_0004584 |
| Disease | carnitine measurement | 4.17e-03 | 76 | 125 | 3 | EFO_0010469 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVESSLGKEKGLEIL | 281 | O14727 | |
| GGPLVAKETVKLAEE | 151 | Q6DHV7 | |
| LGLSTGEKEKLPGEL | 186 | O75821 | |
| PLGKLDISEIKEEVL | 446 | P13611 | |
| KVDTGVILEEGELKD | 641 | Q9P2I0 | |
| EVEGLKDLLVGPGVE | 661 | Q92974 | |
| PAKKVLTLEGDLVLG | 21 | Q14416 | |
| KITDIIGKEEGIGPE | 1781 | Q13085 | |
| KLKGDVDVSLPEVEG | 1336 | Q09666 | |
| VEGEIKAPDVDIKGP | 1476 | Q09666 | |
| DVDVSLPKVEGDLKG | 1596 | Q09666 | |
| LPKVEGDLKGPEIDV | 1601 | Q09666 | |
| VKGDVDVSVPKLEGD | 1936 | Q09666 | |
| VKGDVDVSLPKLEGD | 2131 | Q09666 | |
| IKGDVDVSAPKLEGE | 2326 | Q09666 | |
| KGEVDVDVPKLEGDL | 2401 | Q09666 | |
| KADVDISGPKVDIEG | 2536 | Q09666 | |
| DVDVSLPKVEGDLKG | 2596 | Q09666 | |
| LPKVEGDLKGPEVDI | 2601 | Q09666 | |
| VKGDVDVSLPKVEGD | 2721 | Q09666 | |
| VDIKGPKVDIDAPDV | 2741 | Q09666 | |
| DLNLTGPKIKGDVDV | 2841 | Q09666 | |
| GPEVDLKGPKVDIDV | 2866 | Q09666 | |
| KGDVVVSLPKVEGDL | 3686 | Q09666 | |
| VSLPKVEGDLKGPEV | 3691 | Q09666 | |
| DVDVSLPKVEGDLKG | 4146 | Q09666 | |
| LPKVEGDLKGPEVDI | 4151 | Q09666 | |
| VKGDVDVSLPKVEGD | 4271 | Q09666 | |
| VDIKGPKVDIDAPDV | 4291 | Q09666 | |
| GDVDVSLPKVEGDLK | 4401 | Q09666 | |
| KGDVDVTLPKVEGDL | 4736 | Q09666 | |
| VPKVEGTLKGPEVDL | 4871 | Q09666 | |
| DLEEGGLDLTVSLKP | 121 | Q9H8G2 | |
| LDLLEGLTGQKLPKE | 51 | P11532 | |
| EEEEKSGLGAKIPVT | 31 | Q5RIA9 | |
| PKGKEKEVDGLLTSE | 576 | Q8WWM7 | |
| DKVELEVTLPGEGKD | 111 | Q9UKV8 | |
| GKAELEIQKDALEPG | 106 | P07741 | |
| ELLEGKILPGVEALS | 401 | P07205 | |
| PEELKVKVLGDVIEV | 86 | P02511 | |
| EDKGKLFGVEIEIID | 111 | Q9Y5G5 | |
| EVEEPLGVEKKGGEE | 481 | A6NDB9 | |
| PLAVADAKLGGVIKE | 86 | Q9Y2X3 | |
| IEDPKLGKVTLEIAI | 1041 | Q96RG2 | |
| KIPELGGKDVEDLFT | 1511 | Q8NEZ4 | |
| KVKPEERLTIEGVLD | 286 | Q8IW41 | |
| GPVTAIKLLGEENKE | 156 | Q9NQ76 | |
| IKGIDEGPEGLKLIS | 121 | Q8N335 | |
| EGPEGLKLISDIIRE | 126 | Q8N335 | |
| QPELKRIKTEDGEGI | 626 | Q01167 | |
| DIVKELKENGELLPI | 316 | O76003 | |
| DLKLPEGELGKEIEG | 111 | Q9GZV4 | |
| KGEIEEDLKPNGVLS | 1661 | Q15652 | |
| PEDGALLGKIEKVRV | 181 | Q10471 | |
| EEEEKSGLGAKIPVT | 31 | Q8IUF1 | |
| EEEEKSGLGAKIPVT | 31 | Q9BRT8 | |
| LKEGDEILDVNGIPI | 631 | O15018 | |
| EEGLKRLKEGDLPVT | 331 | Q8IYB4 | |
| SGLKEELIPEKLERV | 636 | Q6N069 | |
| IPIVESEIKKEAGEL | 486 | P53618 | |
| AEEVGKTLLSLEGKP | 516 | Q6ZNL6 | |
| GKEDALVTKNLVPGE | 101 | P22087 | |
| GKEIEGEEIEIVLAK | 396 | O43390 | |
| FGEKLKGTDPEETIL | 146 | Q9BUA6 | |
| GGRDPITGVKLKEVE | 441 | Q8WVZ9 | |
| ISLGKVGVKEEVLPV | 2001 | P46013 | |
| ELLEGKVLPGVDALS | 401 | P00558 | |
| DGLLSGKEETRKIPV | 66 | Q9NRX1 | |
| LIGTEEIIKEEEEGK | 421 | P23471 | |
| GLAEGLESEKKAVIP | 1626 | P23471 | |
| ELDGLKIPSESGEKL | 336 | Q969R2 | |
| LKGIEEEEILPGFIL | 366 | P15170 | |
| KEGIDKIRLTGGEPL | 116 | Q9NZB8 | |
| EKPPDDELVKGLGLI | 181 | Q9UN74 | |
| EKVELVTGEEGEKVL | 1046 | A6NKT7 | |
| DRGEKGKIGETLVLP | 186 | P0C862 | |
| LIKDVFPGIELKEVE | 1921 | Q8NCM8 | |
| GPKGDLGLTKEEIIK | 766 | Q2UY09 | |
| IKGIDPDLLKEGKLE | 306 | P10912 | |
| KESLDGPIVKQLERG | 851 | O75460 | |
| GEEVGPLELEIKRLS | 746 | Q4G0X9 | |
| EKILLFTTDGPEGLK | 211 | Q6UWU2 | |
| EEEEKSGLGAKIPVT | 31 | Q5JTY5 | |
| EEEEKSGLGAKIPVT | 31 | Q4V339 | |
| DRGEKGKIGETLVLP | 186 | B2RNN3 | |
| EVLDGRKPTGGKLEV | 816 | Q5T0F9 | |
| QSKLEVIEEEGKVGP | 3461 | Q12955 | |
| LGKEIIEVQKDPEAL | 611 | Q8NEU8 | |
| PTIDIEILKGEKGEA | 61 | P60827 | |
| DIELKLGRKVPESLV | 11 | Q8IV03 | |
| EGEKLVEEALEKAPG | 231 | P09913 | |
| KKLGEESGDEIDVPK | 566 | Q15051 | |
| KEGKGEIRSLVEPLS | 576 | A6NE01 | |
| EGVDISPKQDEGVLK | 21 | Q02790 | |
| LDEGIVAKFKEGPVE | 126 | Q15835 | |
| EVTPDEKLGEKGKEI | 91 | P34947 | |
| LVGGPLVDTDIALKK | 901 | A5D8W1 | |
| DLPVLVGEEGEVKKL | 481 | Q99590 | |
| ISENILEKGGDPLEK | 511 | Q99590 | |
| SPILKRKLGVDGVEE | 4471 | P21817 | |
| DKDVGGPTEEELLKL | 581 | Q9Y597 | |
| ELKKGVDIIIATPGR | 361 | Q9NXZ2 | |
| IEKLKLSEGKGLEGP | 71 | O14713 | |
| GGRDPITGVKLKEVE | 441 | Q86V97 | |
| ILKAIEEIAGVGVPE | 1196 | Q9BXW9 | |
| EEEGGPVLVKEKLGL | 1426 | O94851 | |
| GIEIQEGKEDPLLEK | 711 | Q13615 | |
| ILTDIEEGVLIDKGK | 1731 | P56715 | |
| LGAGEPKTEKEISVL | 481 | Q6ZVC0 | |
| LKGEVLDGKTPVVID | 186 | Q59EK9 | |
| EVLIPLSGIELSEGK | 256 | Q9H2B2 | |
| VETEIPKGSKEGLEI | 791 | Q5TCS8 | |
| PKGSKEGLEIEKLSE | 796 | Q5TCS8 | |
| EKVELVIGEEGEKVL | 1046 | Q7Z3J3 | |
| EKGLPEDDPDIVVKG | 86 | Q7Z736 | |
| LKELGLPSGKNDEIE | 186 | Q15147 | |
| LASGVEAKKGIELIP | 901 | Q15147 | |
| EKPLECIKGEEGIQV | 141 | Q9UPZ6 | |
| KPLELLGEKSEQSGL | 256 | Q969F9 | |
| GGLLKLPEDALVKAE | 121 | P28360 | |
| LLKPENVKVLGGEVD | 181 | Q9H9A7 | |
| GDIKGVIPELEKELS | 396 | A1A5C7 | |
| KVDAIGLELVDGKVL | 2936 | P25391 | |
| NEEPGILVATKDGLK | 11 | Q9NZH4 | |
| VKGGPVQVLEDEELK | 356 | Q13228 | |
| GIEIDAGLEVKVKDP | 2431 | O75592 | |
| DEGKLLEAKGPVTDV | 481 | O75083 | |
| IDKTLGIRGPEDVAK | 96 | P41252 | |
| KEEGVRDVLKDVLLP | 641 | P41252 | |
| KILVVITDGEKFGDP | 251 | P11215 | |
| IGLVTKTDPEKGEIE | 511 | Q8TCS8 | |
| AIGLPEELIQKGKDI | 21 | P07148 | |
| EAIIKEPIDIEEGIK | 201 | Q9P2R7 | |
| EGPGEQETKLDLISK | 241 | Q99808 | |
| KPFDQKELELIIGGL | 621 | Q9HCE7 | |
| GKEVLGLPDEESIKE | 101 | O94911 | |
| LVDIGKQKLPDGSEI | 61 | Q96KP4 | |
| VLDTKPKETGGILGE | 466 | Q96S66 | |
| GTDGKEELKADVVPV | 561 | Q9HAW4 | |
| VIPVKELEEGGNKDE | 71 | Q8WWY7 | |
| ILKLEVEECPAEGKI | 76 | P17025 | |
| GEKLGLADLLEPVKT | 81 | Q5TAP6 | |
| FIEPKIGLKEDGVSE | 126 | Q9Y330 | |
| GIIKVDPKQLLEDGI | 696 | Q12768 | |
| PVDLTGLIAEEKGLV | 421 | P49588 | |
| VSKKTEGKIEELLPG | 136 | P50453 | |
| GPELEEKALVLKQLG | 756 | Q9C0H9 | |
| VEEIIKKQGEGVPDL | 316 | P35813 | |
| GKKDLDGLIKVDPET | 366 | O95171 | |
| VIGLVDAEKLKPGDL | 136 | P17980 | |
| GRPKIDGELKITSVE | 401 | P15498 | |
| ILGKLKELNGTAPEE | 551 | Q9Y263 | |
| LEGLIPEDKVVLLAG | 56 | A6NDN8 | |
| EGEPVTLFEVVKLGK | 81 | Q8WVM7 | |
| SGEKLVLADLLEPVK | 81 | Q9BVJ6 | |
| VEKKLEAFPLGTEVG | 106 | Q96NL6 | |
| EILKEGSVLDILKSP | 601 | P49790 | |
| DLEESPKGGLDILKS | 511 | Q63HK5 | |
| LKNAEESKLGPDIGI | 1346 | Q7Z4N2 | |
| PEETDKLLKRIEVLG | 196 | P52736 | |
| VKPLEKVLLEEGEAQ | 71 | P11441 | |
| SGIPEVDLGIDAKIK | 171 | Q9NZ63 | |
| EGPTLTKVKIEGEPE | 696 | Q15063 | |
| PLVEALKVGEIGKEG | 921 | Q8IWB9 | |
| IKEPEREGKGTDLEK | 271 | Q5SRN2 | |
| TVEKPELFLGLKIGE | 1076 | O60293 | |
| GGEEVILKGSPEEKV | 1411 | Q5VUA4 | |
| LEKDPGVLDGATELL | 66 | Q14202 |